Trial intelligence / Profile preview

Xyrem and Modafinil for Daytime Sleepiness in Narcolepsy

NCT00066170Phase 3Completed

Sponsor
Jazz Pharmaceuticals plc
Start
Apr 2003
Primary completion
Jul 2004
Modality
Small Molecules
Countries
4
01

Overview

A Phase 3 trial of sodium oxybate in narcolepsy, sponsored by Jazz Pharmaceuticals plc. Started Apr 2003; status: completed.

02

Drugs

sodium oxybate
03

Conditions

narcolepsy

Beyond the preview

Go deeper on NCT00066170.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00066170.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call